Skip to main content
. 2016 Nov 2;33(12):2242–2256. doi: 10.1007/s12325-016-0436-0

Table 3.

Factors affecting Japanese patients’ preference regarding SDM

Characteristics Overall [ORs (95% CI)] CD [ORs (95% CI)] UC [ORs (95% CI)]
Age (reference ≤40 years)
 41–60 years 1.26 (0.92–1.73) 1.62 (0.72–3.62) 1.24 (0.87–1.78)
 >60 years 1.00 (0.56–1.80) 0.52 (0.06–4.24) 1.05 (0.55–1.99)
Gender (reference male)
 Female 1.17 (0.82–1.68) 1.12 (0.39–3.19) 1.21 (0.81–1.82)
Marital status (reference single)
 Married 1.40 (1.00–1.92) 1.45 (0.61–3.43) 1.48 (1.012.17)
Highest education (reference college or less)
 Bachelor’s degree 0.79 (0.59–1.06) 0.72 (0.32–1.66) 0.73 (0.53–1.02)
 Master’s degree 1.07 (0.61–1.89) 0.94 (0.20–4.39) 1.07 (0.56–2.02)
Occupation
 Full time 1.38 (0.47–4.01) 0 (Omitted) 0.97 (0.30–4.39)
 Part time 1.13 (0.36–3.50) 0 (Omitted) 0.65 (0.19–2.26)
 Self-employed 0.72 (0.23–2.27) 0 (Omitted) 0.62 (0.17–2.20)
 Housewife 1.56 (0.50–4.86) 0 (Omitted) 0.99 (0.29–3.44)
 Student 1.56 (0.16–14.72) 0 (Omitted) 0 (Omitted)
 Unemployed/pensioners 1.70 (0.56–5.15) 0 (Omitted) 1.28 (0.37–4.39)
Household incomes (reference less than 2 M JPY)
 2–4 M JPY 1.41 (0.48–4.12) 0 (Omitted) 1.00 (0.31–3.26)
 4–6 M JPY 1.13 (0.37–3.56) 0 (Omitted) 0.66 (0.19–2.31)
 6–8 M JPY 0.73 (0.23–2.31) 0 (Omitted) 0.63 (0.18–2.27)
 8–10 M JPY 1.58 (0.50–4.97) 0 (Omitted) 1.01 (0.29–3.54)
 More than 10 M JPY 1.59 (0.17–15.10) 0 (Omitted) 0 (Omitted)
Comorbidity
 Dyslipidemia 1.82 (1.083.08) 0.73 (0.10–5.08) 1.66 (0.93–2.98)
 Hypertension 0.95 (0.61–1.49) 2.65 (0.47–15.09) 0.83 (0.50–1.36)
 COPD asthma 3.61 (1.419.26) 0 (Omitted) 2.26 (0.83–6.17)
 Diabetes 0.59 (0.32–1.10) 0 (Omitted) 0.44 (0.220.88)
 Depression 1.64 (0.91–2.96) 1.10 (0.21–5.74) 1.69 (0.87–3.30)
 OA and RA 0.61 (0.12–3.16) 0 (Omitted) 1.00 (0.16–6.27)
 Gastrointestinal disease 0.68 (0.34–1.34) 0.11 (0.01–1.24) 0.82 (0.39–1.75)
Surgical history
 Previous surgical 1.66 (1.132.42) 1.49 (0.67–3.31) 1.94 (1.123.36)
Time since diagnosis (reference 0–2 years)
 3–8 years 0.70 (0.46–1.08) 0.54 (0.09–3.21) 0.75 (0.46–1.18)
 9–15 years 0.67 (0.42–1.07) 0.30 (0.05–1.93) 0.78 (0.47–1.29)
 >15 years 0.79 (0.49–1.27) 0.93 (0.15–5.56) 0.71 (0.42–1.20)
Current treatment
 Nutritional 1.20 (0.82–1.75) 1.50 (0.69–3.26) 1.12 (0.66–1.91)
 5-ASA 1.08 (0.72–1.63) 1.25 (0.53–2.99) 1.01 (0.60–1.72)
 Steroid 1.40 (0.95–2.09) 4.20 (0.98–17.98) 1.18 (0.75–1.84)
 Immunosuppressant 0.93 (0.62–1.41) 0.64 (0.28–1.48) 1.09 (0.65–1.82)
 Biologic agents 1.76 (1.172.65) 1.81 (0.78–4.23) 1.89 (1.023.50)
 Cytapheresis 1.61 (0.44–5.85) 0 (Omitted) 1.82 (0.49–6.78)
Type of hospitals (reference university hospital)
 General/specialist hospital 0.64 (0.460.90) 1.06 (0.48–2.33) 0.52 (0.350.78)
 Clinics 0.61 (0.400.92) 0.12 (0.020.57) 0.61 (0.380.97)
Frequency of visits (reference more than once in a month)
 Once every month 0.85 (0.49–1.48) 0.65 (0.16–2.66) 1.02 (0.53–1.96)
 Once every 2 months 0.90 (0.51–1.60) 0.62 (0.15–2.56) 1.09 (0.55–2.18)
 Once every 3 months 1.06 (0.57–2.00) 0.36 (0.69–1.92) 1.41 (0.68–2.94)
 Less than every 3 months 0.62 (0.30–1.30) 0.13 (0.01–1.91) 0.86 (0.36–2.01)

CD Crohn’s disease, UC ulcerative colitis, COPD chronic obstructive pulmonary disease, OA osteoarthritis, RA rheumatoid arthritis, 5-ASA 5-aminosalicylic acid

Bold values indicate significance at 5% level or higher